Results 241 to 250 of about 424,358 (303)

A negative survival pressure selection system enables GPCR antagonist screening. [PDF]

open access: yesCell Discov
Xu T   +10 more
europepmc   +1 more source

Mitochondria and Neuromast Tagging With Fluorescent Gallium‐Triapine Analogues: In Cellulo MP FLIM and Zebrafish Live Imaging

open access: yesAdvanced Science, EarlyView.
Fluorescent BODIPY‐conjugated thiosemicarbazone ligands and their Ga(III), In(III), and Fe(III) complexes, inspired by Triapine, are developed as theranostic agents. Multiphoton FLIM and confocal microscopy in cancer cells and zebrafish reveal real‐time uptake, mitochondrial localisation, and whilst spectroscopic assays indicated preserved complex ...
Megan J. Green   +15 more
wiley   +1 more source

Mitigating Cancer Therapy–Related Cognitive Impairment by Targeted Activation of Undruggable Phosphatase

open access: yesAdvanced Science, EarlyView.
An RVG‑engineered exosomal saRNA delivery system (RVG‑EVs‑saPtpro) effectively targets and activates hippocampal PTPRO, functioning as a “molecular brake” to alleviate cancer therapy‑related cognitive impairment (CTRCI) by enhancing neuronal survival, neurogenesis, and synaptic plasticity.
Zhimeng Yao   +18 more
wiley   +1 more source

Strategic applications of heterocyclic compounds in pharmaceutical innovation: a business perspective. [PDF]

open access: yesFront Chem
Dong Y   +6 more
europepmc   +1 more source

Increasing access to CAR-T therapy: a case study of an academic hospital's alternative innovation model. [PDF]

open access: yesOrphanet J Rare Dis
Ruiz AA   +5 more
europepmc   +1 more source

Quantifying public and private investment in biopharmaceutical R&D: a study of seven middle- and high-income countries. [PDF]

open access: yesJ Pharm Policy Pract
Fowler A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy